Kent W Mouw

21PUBLICATIONS
202CO-AUTHORS
Molecular targetsSequence analysisCancer diagnosisGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Oct 25, 2026
SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers.

|Sep 28, 2026
Identification of an ERCC2 Mutation-Associated Mutational Signature of Nucleotide Excision Repair Deficiency in Targeted Panel Sequencing Data.

|Sep 10, 2026
Somatic likelihood tiering: an interpretable post-calling triage protocol for tumor-only whole-exome variant review.

|Aug 24, 2026
A Phase II Study of Berzosertib in Combination with Carboplatin Compared with Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer.

|Aug 05, 2026
Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group.

|Feb 24, 2026
Epigenetic Atlas of Bladder Cancer Reveals Master Transcription Factors and Risk-Associated Regulatory Elements in Luminal and Basal-Squamous Molecular Subtypes.

Elio Adib, Amin H Nassar, Sarah Abou Alaiwi

Pageof 4

Frequent Collaborators

4 joint publications

Zoltan Szallasi

4 joint publications

Sophia C Kamran

4 joint publications

Eliezer Van Allen

3 joint publications

David T Miyamoto